Sarcopenia is a prognostic factor for TKIs in metastatic thyroid carcinomas.
Haruhiko YamazakiKiminori SuginoKenichi MatsuzuChie MasakiJunko AkaishiKiyomi HamesChisato TomodaAkifumi SuzukiTakashi UrunoKeiko OhkuwaWataru KitagawaMitsuji NagahamaMunetaka MasudaKouichi ItoPublished in: Endocrine (2019)
Sarcopenia could be a predictive factor of TKI treatment outcomes in patients with metastatic thyroid cancer as well as intervention target to improve prognosis. Further prospective investigations are needed to confirm these preliminary data.